Evotec SE, a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and m...
OncoMed Pharmaceuticals Competitors or Alternatives
OncoMed Pharmaceuticals's top competitors include Tarveda, AVEO and CytomX.
OncoMed Pharmaceuticals VS Tarveda
Tarveda is perceived as one of OncoMed Pharmaceuticals's biggest rivals. Tarveda's headquarters is in Watertown, Massachusetts, and was founded in 2011. Tarveda operates in the Biotechnology industry. Tarveda generates 20% of OncoMed Pharmaceuticals's revenue.
Looking for similar companies to OncoMed Pharmaceuticals?
Similar Companies
Biotechnology companies in Redwood City
See 48 companies
Companies in Redwood City with revenue in $25-100M rangeSee 131 companies
Pharmaceuticals & Biotechnology companies in Redwood CitySee 60 companies
Companies in Redwood City with employees in 1-25 rangeSee 272 companies
Biotechnology companies with revenue in $25-100M rangeSee 862 companies
Biotechnology companies in San Francisco Bay AreaSee 1,319 companies
Pharmaceuticals & Biotechnology companies with revenue in $25-100M rangeSee 1,457 companies
Pharmaceuticals & Biotechnology companies in San Francisco Bay AreaSee 1,673 companies
Biotechnology companies in CaliforniaSee 3,096 companies
Trending News for OncoMed Pharmaceuticals and OncoMed Pharmaceuticals's Competitors
The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Tepezza (teprotumumab), for the t...
As many as half of patients with high-risk NMIBC experience disease recurrence despite BCG treatment...
KEYNOTE-689 marks the first positive trial in more than two decades for patients with resected locally advanced head and neck squamous cell carcinoma (...
The Korea Health Industry Development Institute (KHIDI) and AstraZeneca Korea have jointly supported the entry of leading Korean pharmaceutical and bio...
In This Article: AbbVie ( NYSE:ABBV ) First Quarter 2025 Results Key Financial Results Revenue: US$13.3b (up 8.4% from 1Q 2024). Net income: US$1.29b (...
In This Article: Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2025 Results Key Financial Results Revenue: US$11.2b (down 5.6% from 1Q 2024). Net inc...
Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number...
MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell carcinoma (LA-HNSCC). The post MS...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him D...
Frequently Asked Questions about OncoMed Pharmaceuticals
Who are OncoMed Pharmaceuticals's top competitors?
OncoMed Pharmaceuticals's top 3 competitors are Tarveda, AVEO, CytomX.Who is similar to OncoMed Pharmaceuticals?
Tarveda is the most similar to OncoMed Pharmaceuticals. AVEO and CytomX are also similar to OncoMed Pharmaceuticals.
Are OncoMed Pharmaceuticals and Tarveda competitors?
Yes, Tarveda is one of OncoMed Pharmaceuticals’s top competitors.